MediThinQ, a South Korea-based developer of surgical visualisation technologies, has signed an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. (Synovis MCA),

WISE S.p.A., a medical device company focused on implantable electrodes for neuromonitoring, neuromodulation and brain-computer interface (BCI) applications, has completed an oversubscribed Series D financing round worth €30 million.

Oculogica has received US Food and Drug Administration (FDA) 510(k) clearance for its SNAP concussion test, a non-invasive diagnostic tool designed to assess concussion in just 90 seconds.

Penumbra, Inc. has received CE Mark approval in Europe for THUNDERBOLT, its computer assisted vacuum thrombectomy (CAVT) technology for the treatment of acute ischaemic stroke. The milestone follows recent clearance

Chiesi Group, a research-focused biopharmaceutical company, has completed its acquisition of KalVista Pharmaceuticals. KalVista will now operate as part of Chiesi’s Rare Diseases business unit

Wave Neuroscience, in collaboration with the Texas A&M Health Institute of Biosciences and Technology, has received clearance from the U.S. Food and Drug Administration (FDA) for its MeRT System for the treatment of Post-Traumatic Stress Disorder (PTSD).

DataFirst and Konica Minolta Healthcare Americas have announced a partnership to deliver enhanced interoperability and DICOM routing capabilities for healthcare organisations using Exa® PACS|RIS and Exa® Teleradiology platforms.

W. L. Gore & Associates has received CE Mark approval under the Medical Device Regulation (MDR) for its GORE VIABAHN FORTEGRA Venous Stent. The device is intended for the treatment of symptomatic

Northwell Health has announced that a critically ill patient at North Shore University Hospital has become one of the first patients in the United States, and the first on the East Coast, to be successfully treated with the AeroPace

Clarify Health has completed the acquisition of Loyal Health Holdings, creating what the company describes as the healthcare industry's first closed-loop network intelligence and patient activation platform.